002773.SZ
康弘药业
SZSE · Healthcare · C 制造业 · CN
CNY 20.48
−2.98%Margins
Gross margin
89.6%
EBITDA margin
36.5%
EBIT margin
28.7%
Net margin
24.1%
FCF margin
25.5%
11.1%
Return on equity
10.5%
Return on assets
13.2%
Return on invested capital
0.44x
Asset turnover
CNY 1.4B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026